[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369483-105":59,"doc-detail-369483-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","identification-and-functional-characterization-of-hub-genes-clta-edil3-hapln1-and-hip1-as-diagnostic-biomarkers-and-therapeutic-targets-in-thyroid-cancer-and-hashimotos-thyroiditis","Identification and functional characterization of hub genes CLTA, EDIL3, HAPLN1, and HIP1 as diagnostic biomarkers and therapeutic targets in thyroid cancer and Hashimoto’s thyroiditis","","This study identifies key molecular players shared by thyroid cancer (TC) and Hashimoto’s thyroiditis (HT) by analyzing differentially expressed genes and evaluating their biomarker potential. Using Gene Expression Omnibus (GEO) datasets, CLTA, EDIL3, HAPLN1, and HIP1 are found as common hub genes, upregulated in TC cells with strong diagnostic performance by ROC analysis. TCGA validation confirms tumor-specific upregulation, hypomethylation patterns, and relevant mutations/CNVs. Meta-analysis links higher HAPLN1 and HIP1 expression to poorer TC survival, while CLTA and EDIL3 implicate Rap1 signaling in migration, proliferation, and invasion.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-and-functional-characterization-of-hub-genes-clta-edil3-hapln1-and-hip1-as-diagnostic-biomarkers-and-therapeutic-targets-in-thyroid-cancer-and-hashimotos-thyroiditis/369483/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-and-functional-characterization-of-hub-genes-clta-edil3-hapln1-and-hip1-as-diagnostic-biomarkers-and-therapeutic-targets-in-thyroid-cancer-and-hashimotos-thyroiditis/369483.png","ImageObject",300,407,{"name":92,"@type":93},"Maya Linwood","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Which hub genes are identified as shared between thyroid cancer and Hashimoto’s thyroiditis?","Question",{"text":113,"@type":114},"CLTA, EDIL3, HAPLN1, and HIP1 are identified as hub genes common to both thyroid cancer (TC) and Hashimoto’s thyroiditis (HT).","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are the diagnostic biomarker capabilities of these genes evaluated?",{"text":118,"@type":114},"Their diagnostic accuracy is assessed using Receiver Operating Characteristic (ROC) curve analysis, showing strong performance in distinguishing TC from normal controls.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanisms and outcomes does the study associate with these hub genes?",{"text":122,"@type":114},"Promoter methylation suggests hypomethylation in TC, CNVs and mutations support gene dysregulation, and meta-analysis links higher HAPLN1 and HIP1 expression to poor survival; CLTA and EDIL3 are linked to Rap1 signaling relevant to tumor progression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369483,1790211354,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Clinical and Experimental Medicine (2025) 25:162 [https://doi.org/10.1007/s10238-025-01689-w](https://doi.org/10.1007/s10238-025-01689-w)  \nIdentification and functional characterization of hub genes CLTA, EDIL3, HAPLN1, and HIP1 as diagnostic biomarkers and therapeutic targets in thyroid cancer and Hashimoto’s thyroiditis  \nTianyu Liu1 · Dechun Zhang1 · Wen Ouyang2 · Rongfang Li1 · Siying Wang1 · Weixuan Liu1  \nReceived: 11 March 2025 / Accepted: 14 April 2025 / Published online: 15 May 2025 © The Author(s) 2025  \nAbstract  \nIn this study, we sought to identify key molecular players in both thyroid cancer (TC) and Hashimoto's thyroiditis (HT) by analyzing differentially expressed genes (DEGs) and their potential as biomarkers. We utilized datasets from the Gene Expression Omnibus (GEO) database and identified CLTA, EDIL3, HAPLN1, and HIP1 as hub genes common to both TC and HT. These genes were significantly upregulated in TC cell lines compared to normal controls, with high diagnostic accuracy as indicated by Receiver Operating Characteristic (ROC) curve analysis. Further validation using the TCGA TC dataset revealed their significant upregulation in tumor tissues, particularly in advanced TC stages. Promoter methylation analysis indicated hypomethylation of these genes in TC, suggesting a role of methylation in their regulation. We also observed mutations and copy number variations (CNVs) in these hub genes, with CLTA and HIP1 showing significant amplifications, which may contribute to their overexpression in tumor samples. In addition, we conducted a meta-analysis to assess the impact of these genes on survival outcomes in TC patients, with results indicating that higher expression of HAPLN1 and HIP1 was associated with poor survival. Our study also highlighted the involvement of CLTA and EDIL3 in activating the Rap1 signaling pathway, crucial for cancer cell migration, proliferation, and invasion. These findings emphasize the potential of CLTA, EDIL3, HAPLN1, and HIP1 as diagnostic biomarkers and therapeutic targets for TC and HT.  \nKeywords Thyroid cancer · Hashimoto’s thyroiditis · Biomarker · Therapeutic target · Proliferation  \n* Weixuan Liu [13875107306@163.com](13875107306@163.com)  \nTianyu Liu  \n[lty19840519@163.com](lty19840519@163.com)  \nDechun Zhang  \n[769292228@qq.com](769292228@qq.com)  \nWen Ouyang  \n[hfqbx4@163.com](hfqbx4@163.com)  \nRongfang Li  \n[331702375@qq.com](331702375@qq.com)  \nSiying Wang  \n[307970119@qq.com](307970119@qq.com)  \n1 Department of Geriatrics, Changde Hospital, Xiangya School of Medicine, Central South University, Changde 415000, China  \n2 Department of Medical Affairs, Changde Hospital, Xiangya School of Medicine, Central South University, Changde 415000, China  \nIntroduction  \nHashimoto's thyroiditis (HT) and thyroid cancer (TC) are two prevalent thyroid disorders with distinct pathophysiological mechanisms yet some overlapping molecular characteristics [1, 2] . HT is an autoimmune disease that leads to chronic inflammation of the thyroid gland, often resulting in hypothyroidism [3, 4] . It is marked by an infiltration of immune cells, particularly lymphocytes, and the production of thyroid-specific autoantibodies that cause thyroid cell destruction [5, 6] . On the other hand, TC is a malignant tumor of the thyroid gland, with the most common form being papillary thyroid carcinoma (PTC), followed by follicular, medullary, and anaplastic types [7] . Both diseases present distinct molecular features; however, their relationship and shared molecular pathways have not been extensively explored. The global prevalence of HT is increasing, with estimates suggesting that around 5% of the global population is affected, with a significant female predominance [8] . HT is most commonly diagnosed in individuals aged  \n30–50 years, and its prevalence has risen in recent decades due to improved diagnostic methods and heightened awareness [9] . In 2024, it is expected that over 400 million people globa","cbCaiefAU0gTAb4C","https://ap.wps.com/l/cbCaiefAU0gTAb4C","pdf",3301355,"English","# Introduction\n## Background on HT and TC\n## Diagnostic limitations and research gap\n## Study objective and bioinformatics approach","[{\"question\":\"Which hub genes are identified as shared between thyroid cancer and Hashimoto’s thyroiditis?\",\"answer\":\"CLTA, EDIL3, HAPLN1, and HIP1 are identified as hub genes common to both thyroid cancer (TC) and Hashimoto’s thyroiditis (HT).\"},{\"question\":\"How are the diagnostic biomarker capabilities of these genes evaluated?\",\"answer\":\"Their diagnostic accuracy is assessed using Receiver Operating Characteristic (ROC) curve analysis, showing strong performance in distinguishing TC from normal controls.\"},{\"question\":\"What mechanisms and outcomes does the study associate with these hub genes?\",\"answer\":\"Promoter methylation suggests hypomethylation in TC, CNVs and mutations support gene dysregulation, and meta-analysis links higher HAPLN1 and HIP1 expression to poor survival; CLTA and EDIL3 are linked to Rap1 signaling relevant to tumor progression.\"}]","Identification and functional characterization of hub genes CLTA, EDIL3, HAPLN1, and HIP1 as diagnostic biomarkers and therapeutic targets in thyroid cancer and Hashimoto’s thyroiditis | PDF",1790182942,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d187db58eff5e6e966afb155b28b3633.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/874baa06d0c195e81938b6a655c04c0b.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7e2ca5efc3a369cb8151a23d1dff855.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f74a9719e75353ad4ba1536c49310560.webp",980,1301]